课题基金 / 基金详情

A PHASE III TRIAL OF A LOW FAT DIET IN STAGE II BREAST C

A PHASE III TRIAL OF A LOW FAT DIET IN STAGE II BREAST C
II 期乳房 C 低脂饮食的 III 期试验
批准号:
3548417
负责人:
DANIEL W NIXON
金额:
$1.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-09-01 至 1986-04-30

项目摘要

项目成果

DANIEL W NIXON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer remains the primary cause of cancer death in American women. Although some improvement in morbidity and mortality has resulted from adjuvant chemotherapy in Stage II breast cancer patients, the death rate in this group is significant. This project seeks to impact further on this subset of patients by utilizing another treatment modality, nutritional intervention. The influence of dietary fat on the incidence of breast cancer has been supported by epidemiological data. Whether an increase in dietary fat intake also influences recurrence has not been investigated. However, overweight and obese women have a greater and earlier recurrence rate of breast cancer than patients of normal weight. This study investigates the influence of nutritional counseling to attain a low dietary fat intake (20% of calories) on the recurrence rate of Stage II breast cancer patients receiving adjuvant chemotherapy. Patients will be evaluated with nutritional histories and diaries prior to the institution of therapy. Accessioned patients will be randomized to control or treatment groups. Nutritional treatment will consist of both individual and group sessions which use specific techniques to encourage compliance with the restricted fat intake. Patients will be evaluated regarding fat intake monthly during the treatment period and every three months after chemotherapy is completed. Control patients will be evaluated at the same intervals. Follow-up will continue for five years or until recurrence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
START- STRATEGIC TIMING OF ANTIRETROVIRAL THERAPY
  • 批准号:
    8166579
  • 项目类别:
  • 资助金额:
    $0.07万
  • 财政年份:
    2009
  • 负责人:
    DANIEL W NIXON
  • 依托单位:
STUDY A5235: A PHASE II, RANDOMIZED, DOUBLE-BLIND STUDY OF MINOCYCLINE IN THE
  • 批准号:
    8166560
  • 项目类别:
  • 资助金额:
    $1.02万
  • 财政年份:
    2009
  • 负责人:
    DANIEL W NIXON
  • 依托单位:
CLINICAL TRIAL: A PHASE III COMPARATIVE STUDY OF THREE NON-NUCLEOSIDE REVERSE TR
  • 批准号:
    8166580
  • 项目类别:
  • 资助金额:
    $0.95万
  • 财政年份:
    2009
  • 负责人:
    DANIEL W NIXON
  • 依托单位:
CLINICAL TRIAL: PHASE III STUDY OF SUBCUTANEOUS RECOMBINANT IL-2 IN PATIENTS W/
  • 批准号:
    7950848
  • 项目类别:
  • 资助金额:
    $4.15万
  • 财政年份:
    2008
  • 负责人:
    DANIEL W NIXON
  • 依托单位:
海外基金